| Metric | Q2 2025 | Q1 2025 | Q2 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $192M | $159M | $77M | 20.4% | 149.7% |
| Op. Income | $40M | $11M | -$24M | 252.5% | 263.4% |
| Gross Margin | 75.8% | 74.9% | 77.9% | 1.0pp | -2.0pp |
| Net Margin | 26.7% | 20.0% | -9.8% | 6.7pp | 36.5pp |
| EPS (Diluted) | $0.29 | $0.18 | $-0.05 | 61.1% | 696.7% |
| Free Cash Flow | $133M | $6M | $31M | 2135.4% | 328.2% |
| Item | Amount |
|---|---|
| REVENUE | $192M |
| Cost of Revenue | $46M |
| GROSS PROFIT | $146M |
| R&D Expenses | $67M |
| Selling & Marketing | $19M |
| General & Administrative | $20M |
| SG&A Expenses | $39M |
| Other Expenses | $0 |
| Operating Expenses | $106M |
| Cost & Expenses | $152M |
| OPERATING INCOME | $40M |
| Interest Income | $11M |
| Interest Expense | $0 |
| Other Income/Expenses | $11M |
| INCOME BEFORE TAX | $51M |
| Income Tax Expense | -$560.0K |
| Net Income from Continuing Ops | $51M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $51M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $51M |
| D&A | $1M |
| EBIT | $40M |
| EBITDA | $41M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $192M |
| Cost of Revenue | $46M |
| GROSS PROFIT | $146M |
| R&D Expenses | $67M |
| Selling & Marketing | $19M |
| General & Administrative | $20M |
| SG&A Expenses | $39M |
| Other Expenses | $0 |
| Operating Expenses | $106M |
| Cost & Expenses | $152M |
| OPERATING INCOME | $40M |
| Interest Income | $11M |
| Interest Expense | $0 |
| Other Income/Expenses | $11M |
| INCOME BEFORE TAX | $51M |
| Income Tax Expense | -$560.0K |
| Net Income from Continuing Ops | $51M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $51M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $51M |
| D&A | $1M |
| EBIT | $40M |
| EBITDA | $41M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $51M |
| Depreciation & Amortization | $1M |
| Stock-Based Compensation | $35M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $2M |
| Change in Working Capital | $45M |
| OPERATING CASH FLOW | $135M |
| Capital Expenditure | -$2M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$214M |
| Sales/Maturities of Investments | $152M |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$64M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $4M |
| NET CASH FROM FINANCING | $5M |
| FREE CASH FLOW | $133M |
| Net Change in Cash | $76M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $162M |
| Short-Term Investments | $903M |
| Net Receivables | $24M |
| Inventory | $59M |
| Other Current Assets | $33M |
| TOTAL CURRENT ASSETS | $1.2B |
| PP&E (Net) | $62M |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $0 |
| Tax Assets | $0 |
| Other Non-Current Assets | $29M |
| TOTAL NON-CURRENT ASSETS | $91M |
| TOTAL ASSETS | $1.3B |
| Account Payables | $32M |
| Short-Term Debt | $0 |
| Deferred Revenue | $10M |
| Other Current Liabilities | $43M |
| TOTAL CURRENT LIABILITIES | $106M |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $29M |
| TOTAL NON-CURRENT LIABILITIES | $29M |
| TOTAL LIABILITIES | $136M |
| Common Stock | $17.0K |
| Additional Paid-In Capital | $1.3B |
| Retained Earnings | -$126M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $3M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.1B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.1B |
| TOTAL LIABILITIES & EQUITY | $1.3B |
| Total Debt | $0 |
| Net Debt | -$162M |
